x

Search for a clinical trial

* (*) mandatory field

110 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
AOA1 : Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 (Phase III)
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Institut du Cerveau et de la Moëlle épinière - INSERM U1127

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

ILE-DE-FRANCE
PARIS

Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy (Phase II)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Neurologie et thérapeutique expérimentale

FRANCE

PAYS DE LA LOIRE
NANTES

Randomized Placebo-Controlled Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Phase II)
CHU de Nantes - Hôpital Nord Guillaume et René Laënnec
Clinique neurologique

GERMANY

Baden-Württemberg
TÜBINGEN

Treatment Retina Implant Trial - DE
Department für Augenheilkunde Tübingen
Forschungsinstitut für Augenheilkunde

GERMANY

Baden-Württemberg
TÜBINGEN

Rivastigmine (Exelon®) for treatment of dementia in patient with Progressive Supranuclear Paresis - DE
Hertie-Institut für klinische Hirnforschung (HIH)
Abteilung Neurologie mit Schwerpunkt neurodegenerative Erkrankungen

ITALY

LOMBARDIA
MILANO

NETHERLANDS

Zuid-Holland
LEIDEN

SPAIN

Aragón
ZARAGOZA

SPAIN

Aragón
ZARAGOZA

A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease (Phase III) (completed)
Hospital Universitario Miguel Servet
Servicio de Hematología y Hemoterapia

UNITED STATES

New York
NEW YORK

GERMANY

Bayern
MÜNCHEN

SPAIN

Madrid
MADRID

Ongoing trial
Setmelanotide (RM-493): Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Endocrinología, Crecimiento y Metabolismo

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

A Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Patients With Leber's Hereditary Optic Neuropathy (Phase II)
Newcastle University Institute for Ageing (NUIA), Newcastle Biomedicine
Wellcome Trust Centre for Mitochondrial Research (Institute of Neuroscience)

UNITED KINGDOM

West Midlands
BIRMINGHAM

FRANCE

ILE-DE-FRANCE
PARIS

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

ITALY

LAZIO
ROMA

A Novel Therapeutic Strategy Targeting Photoreceptor Oxidative Damage in ABCR-related Retinal Degenerations (Phase I / II )
Policlinico Universitario "A. Gemelli"
Dipartimento per l'assistenza sanitaria di Scienze Oftalmologiche e Otorinolaringoiatriche

SPAIN

Aragón
ZARAGOZA

SPAIN

Murcia
EL PALMAR, MURCIA

Multinational clinical trial(s)